Proinflammatory cytokine-induced tight junction remodeling through dynamic self-assembly of claudins

Molecular Biology of the Cell

Volumn 25, Issue 18, 2014, Pages 2710-2719

  Capaldo, Christopher T ^a   Farkas, Attila E ^a   Hilgarth, Roland S ^a   Krug, Susanne M ^b   Wolf, Mattie F ^a   Benedik, Jeremy K ^a   Fromm, Michael ^b   Koval, Michael ^a   Parkos, Charles ^a   Nusrat, Asma ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN; CLAUDIN 2; CLAUDIN 4; CLAUDIN 7; CYCLIN D1; CYTOKINE; GAMMA INTERFERON; TIGHT JUNCTION PROTEIN; TUMOR NECROSIS FACTOR ALPHA; CLDN2 PROTEIN, HUMAN; CLDN4 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; BIOSENSOR; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; MOLECULAR DYNAMICS; MOUSE; MUCOSA INFLAMMATION; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN TRANSPORT; TIGHT JUNCTION; UPREGULATION; ANIMAL; CACO 2 CELL LINE; CHO CELL LINE; CRICETULUS; HAMSTER; HELA CELL LINE; HUMAN; METABOLISM; PHYSIOLOGY; PROTEIN MULTIMERIZATION;

ANIMALS; CACO-2 CELLS; CHO CELLS; CLAUDIN-4; CLAUDINS; CRICETINAE; CRICETULUS; HELA CELLS; HUMANS; INTERFERON-GAMMA; MICE; PROTEIN MULTIMERIZATION; TIGHT JUNCTIONS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84907186484     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E14-02-0773     Document Type: Article

References (43)

1. Anderson JM, Van Itallie CM (2009). Physiology and function of the tight junction. Cold Spring Harbor Perspect Biol 1, a002584.
2. Baker OJ, Camden JM, Redman RS, Jones JE, Seye CI, Erb L, Weisman GA (2008). Proinflammatory cytokines tumor necrosis factor-alpha and interferon-gamma alter tight junction structure and function in the rat parotid gland Par-C10 cell line. Am J Physiol Cell Physiol 295, C1191-C1201.
3. Bruewer M, Luegering A, Kucharzik T, Parkos CA, Madara JL, Hopkins AM, Nusrat A (2003). Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 171, 6164-6172.
4. Buschmann MM, Shen L, Rajapakse H, Raleigh DR, Wang Y, Wang Y, Lingaraju A, Zha J, Abbott E, McAuley EM, et al. (2013). Occludin OCEL-domain interactions are required for maintenance and regulation of the tight junction barrier to macromolecular flux. Mol Biol Cell 24, 3056-3068.
5. Capaldo CT, Beeman N, Hilgarth RS, Nava P, Louis NA, Naschberger E, Sturzl M, Parkos CA, Nusrat A (2012). IFN-gamma and TNF-alpha-induced GBP-1 inhibits epithelial cell proliferation through suppression of beta-catenin/TCF signaling. Mucosal Immunol 5, 681-690.
6. Capaldo CT, Nusrat A (2009). Cytokine regulation of tight junctions. Biochim Biophys Acta 1788, 864-871.
7. Chavez AM, Morin MJ, Unno N, Fink MP, Hodin RA (1999). Acquired interferon gamma responsiveness during Caco-2 cell differentiation: effects on iNOS gene expression. Gut 44, 659-665.
8. Claude P, Goodenough DA (1973). Fracture faces of zonulae occludentes from "tight" and "leaky" epithelia. J Cell Biol 58, 390-400.
9. Coyne CB, Vanhook MK, Gambling TM, Carson JL, Boucher RC, Johnson LG (2002). Regulation of airway tight junctions by proinflammatory cytokines. Mol Biol Cell 13, 3218-3234.
10. Daugherty BL, Ward C, Smith T, Ritzenthaler JD, Koval M (2007). Regulation of heterotypic claudin compatibility. J Biol Chem 282, 30005-30013.
11. Den Beste KA, Hoddeson EK, Parkos CA, Nusrat A, Wise SK (2013). Epithelial permeability alterations in an in vitro air-liquid interface model of allergic fungal rhinosinusitis. Int Forum Allergy Rhinol 3, 19-25.
12. Furuse M (2010). Molecular basis of the core structure of tight junctions. Cold Spring Harb Perspect Biol 2, a002907.
13. Furuse M, Furuse K, Sasaki H, Tsukita S (2001). Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J Cell Biol 153, 263-272.
14. Gilham DE, Lie ALM, Taylor N, Hawkins RE (2010). Cytokine stimulation and the choice of promoter are critical factors for the efficient transduction of mouse T cells with HIV-1 vectors. J Gene Med 12, 129-136.
15. Gustems M, Borst E, Benedict CA, Perez C, Messerle M, Ghazal P, Angulo A (2006). Regulation of the transcription and replication cycle of human cytomegalovirus is insensitive to genetic elimination of the cognate NF-kappaB binding sites in the enhancer. J Virol 80, 9899-9904.
16. Hering NA, Andres S, Fromm A, van Tol EA, Amasheh M, Mankertz J, Fromm M, Schulzke JD (2011). Transforming growth factor-beta, a whey protein component, strengthens the intestinal barrier by upregulating claudin-4 in HT-29/B6 cells. J Nutr 141, 783-789.
17. Hering NA, Fromm M, Schulzke JD (2012). Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics. J Physiol 590, 1035-1044.
18. Ivanov AI, Samarin SN, Bachar M, Parkos CA, Nusrat A (2009). Protein kinase C activation disrupts epithelial apical junctions via ROCK-II dependent stimulation of actomyosin contractility. BMC Cell Biol 10, 36.
19. Kline JN, Hunninghake GM, He B, Monick MM, Hunninghake GW (1998). Synergistic activation of the human cytomegalovirus major immediate early promoter by prostaglandin E2 and cytokines. Exp Lung Res 24, 3-14.
20. Laukoetter MG, Nava P, Lee WY, Severson EA, Capaldo CT, Babbin BA, Williams IR, Koval M, Peatman E, Campbell JA, et al. (2007). JAM-A regulates permeability and inflammation in the intestine in vivo. J Exp Med 204, 3067-3076.
21. Mankertz J, Schulzke JD (2007). Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications. Curr Opin Gastroenterol 23, 379-383.
22. Mitchell LA, Overgaard CE, Ward C, Margulies SS, Koval M (2011). Differential effects of claudin-3 and claudin-4 on alveolar epithelial barrier function. Am J Physiol Lung Cell Mol Physiol 301, L40-49.
23. Nakamura M, Saito H, Kasanuki J, Tamura Y, Yoshida S (1992). Cytokine production in patients with inflammatory bowel disease. Gut 33, 933-937.
24. Oshima T, Miwa H, Joh T (2008). Changes in the expression of claudins in active ulcerative colitis. J Gastroenterol Hepatol 23(Suppl 2), S146-S150.
25. Piontek J, Fritzsche S, Cording J, Richter S, Hartwig J, Walter M, Yu D, Turner JR, Gehring C, Rahn HP, et al. (2011). Elucidating the principles of the molecular organization of heteropolymeric tight junction strands. Cell Mol Life Sci 68, 3903-3918.
26. Piontek J, Winkler L, Wolburg H, Muller SL, Zuleger N, Piehl C, Wiesner B, Krause G, Blasig IE (2008). Formation of tight junction: determinants of homophilic interaction between classic claudins. FASEB J 22, 146-158.
27. Prasad S, Mingrino R, Kaukinen K, Hayes KL, Powell RM, Mac Donald TT, Collins JE (2005). Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells. Lab Invest 85, 1139-1162.
28. Rahner C, Mitic LL, Anderson JM (2001). Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut. Gastroenterology 120, 411-422.
29. Raleigh DR, Boe DM, Yu D, Weber CR, Marchiando AM, Bradford EM, Wang Y, Wu L, Schneeberger EE, Shen L, et al. (2011). Occludin S408 phosphorylation regulates tight junction protein interactions and barrier function. J Cell Biol 193, 565-582.
30. Salmon P, Trono D (2006). Production and titration of lentiviral vectors. Curr Protoc Neurosci Chapter 4, Unit 4.21.
31. Sasaki H, Matsui C, Furuse K, Mimori-Kiyosue Y, Furuse M, Tsukita S (2003). Dynamic behavior of paired claudin strands within apposing plasma membranes. Proc Natl Acad Sci USA 100, 3971-3976.
32. Schmitz H, Barmeyer C, Fromm M, Runkel N, Foss HD, Bentzel CJ, Riecken EO, Schulzke JD (1999a). Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology 116, 301-309.
33. Schmitz H, Fromm M, Bentzel CJ, Scholz P, Detjen K, Mankertz J, Bode H, Epple HJ, Riecken EO, Schulzke JD (1999b). Tumor necrosis factor-alpha (TNFalpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6. J Cell Sci 112, 137-146.
34. Shen L, Weber CR, Raleigh DR, Yu D, Turner JR (2011). Tight junction pore and leak pathways: a dynamic duo. Annu Rev Physiol 73, 283-309.
35. Shen L, Weber CR, Turner JR (2008). The tight junction protein complex undergoes rapid and continuous molecular remodeling at steady state. J Cell Biol 181, 683-695.
36. Tsukita S, Furuse M (2002). Claudin-based barrier in simple and stratified cellular sheets. Curr Opin Cell Biol 14, 531-536.
37. Van Itallie C, Rahner C, Anderson JM (2001). Regulated expression of claudin-4 decreases paracellular conductance through a selective decrease in sodium permeability. J Clin Invest 107, 1319-1327.
38. Wang F, Graham WV, Wang Y, Witkowski ED, Schwarz BT, Turner JR (2005). Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. J Pathol 166, 409-419.
39. Wray C, Mao Y, Pan J, Chandrasena A, Piasta F, Frank JA (2009). Claudin-4 augments alveolar epithelial barrier function and is induced in acute lung injury. J Physiol Lung Cell Mol Physiol 297, L219-227.
40. Xavier RJ, Podolsky DK (2007). Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427-434.
41. Yamazaki Y, Tokumasu R, Kimura H, Tsukita S (2011). Role of claudin species-specific dynamics in reconstitution and remodeling of the zonula occludens. Mol Biol Cell 22, 1495-1504.
42. Yu D, Marchiando AM, Weber CR, Raleigh DR, Wang Y, Shen L, Turner JR (2010). MLCK-dependent exchange and actin binding region-dependent anchoring of ZO-1 regulate tight junction barrier function. Proc Natl Acad Sci USA 107, 8237-8241.
43. Zeissig S, Burgel N, Gunzel D, Richter J, Mankertz J, Wahnschaffe U, Kroesen AJ, Zeitz M, Fromm M, Schulzke JD (2007). Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 56, 61-72.